To identify the molecular mechanism(s) underlying the activation of p53 induced by SAHA or knockdown of HDAC2, we investigated Mdm2 levels after treatment with SAHA or siRNA targeting HDAC2 in A549 lung cancer cells. This evidence concerns the gene HDAC2 and lung cancer.